对AOPP,IL-6和GDF15的增量值用于识别阻塞性睡眠呼吸暂停患者的动脉硬化

Xinxin Li1,2,3, Wen Liu1,2,3, Yonghuai Wang1,2,3

  • 1Department of Cardiovascular Ultrasound, The First Hospital of China Medical University, No. 155 Nanjingbei Street, Shenyang, 110001, Liaoning, China.

PubMed
概括

增长差异化因子15 (GDF15) 在阻塞性睡眠呼吸暂停 (OSA) 患者的动脉硬化鉴定中具有独立价值. GDF15超越了传统的风险因素和生物标志物,如AOPP和IL-6,提高了诊断准确度.